openPR Logo
Press release

Antibacterial Drugs Market Advancements to Watch Out For 2026 By Top Key Companies Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson

05-27-2019 04:32 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Antibacterial Drugs

Antibacterial Drugs

The global antibacterial drugs market size was valued at US$ 43,791.2 million in 2017, and is expected to exhibit a CAGR of 1.4% over the forecast period (2018 – 2026).Antibacterial drugs are used in treatment or prohibition of bacterial infections caused due to various factors such as climatic changes, unhygienic lifestyle specially in emerging economies and others. Major challenge associated with antibacterial drugs is resistance of bacteria towards it. Significant studies are carried out to develop new antibacterial drugs to combat these problems.

Ask For Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/177

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving antibacterial drugs market growth. According to World Health Organization (WHO), September 2018, annually around 11 million to 21 million cases of typhoid fever are reported worldwide. Moreover, growing geriatric population susceptible to high risk of bacterial infection, majorly caused due to age related changes in immunology is expected to boost the market growth. The Current Opinion in Microbiology Journal 2016, stated Lower respiratory tract infection (Pneumonia), as the most common cause of infection disease in older patients in the U.S. and estimated it as 6 leading cause of death in the U.S.

However, price control of antibacterial drugs, genetic mutation in aging population, and decrease in financial incentives has distracted the focus of pharmaceutical companies from research and development of antibacterial drugs. In September 2016, AstraZeneca announced an agreement with Pfizer to sell the development and commercialization rights to its late-stage small molecule antibiotics business as AstaZeneca does not find antibiotic research as major area for development in their business.

Increasing incidences of infectious diseases is expected to propel growth of the antibacterial drugs market

Antibacterial drugs are used in treatment of infection caused by various bacteria such as Escherichia coli, Klebsiella pneumonia, and others. Moreover, increasing incidences of infectious diseases such as tuberculosis, hepatitis B, leprosy, typhoid, malaria, HIV/AIDS and others is expected to drive the market growth. According to the World Health Organization (WHO) November 2018 factsheet, an estimated 219 million people were diagnosed by malaria in 2017, in 19 countries.

Moreover, initiatives by government concerned to antibacterial resistance is expected to propel market growth over the forecast period. For instance, in May 2018, the UK government announced fund of US$ 34 million to fight against antimicrobial resistance (AMR). This funding will be distributed to the 4 projects such as Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator of US$ 23 million, Global Antibiotic Research and Development Partnership invested US$ 1 million, and US$ 5 million for two project such as bilateral partnership with Argentina and Foundation for Innovative New Diagnostics.

Key Players

Major players operating in the global antibacterial drugs market include Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi SA, Bayer AG, and Pfizer Inc.

Request Customization @ https://www.coherentmarketinsights.com/insight/request-customization/177

Increasing population and high incidences of infectious diseases in North America are expected to bolster the market growth

North America holds dominant position in the global antibacterial drugs market, owing to rising population base susceptible to infectious diseases and higher incidences of infectious diseases such as tuberculosis and others. According to the Centers for Disease Control and Prevention (CDC), in 2017, an estimated 9,105 patients were diagnosed with tuberculosis in the U.S.

Moreover, key players in the market are focused on receiving the U.S. Food and Drug Administration (FDA) approval for novel products to treat patients diagnosed with infectious diseases. For instance, in February 2019, Novartis received the U.S. Food and Drug Administration (FDA) approval for Egaten, used for the treatment of Fascioliasis caused by Fasciola hepatica infection.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibacterial Drugs Market Advancements to Watch Out For 2026 By Top Key Companies Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson here

News-ID: 1754767 • Views: 605

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Antibacterial

Antibacterial Masks Market 2021 | Detailed Report
Global Antibacterial Masks Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures)
Global Antibacterial Drugs Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Antibacterial Drugs Market will expand at a CAGR value of 4.2% to reach USD 41.5 billion by 2026. The increasing demand for efficient and inexpensive antibacterial drugs, and also the increasing number of multi-drug resistant bacterial strains, are some of the primary factors driving the market growth. Browse 117 Market Data Tables and 117 Figures spread through
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an
Antibacterial Filter Market - Key Development by 2027
Antibacterial Filter Market 2020 report focuses on the major drivers and restraints for the Global key players. It also provides analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The recent research report on the global Antibacterial Filter market presents the latest industry data and future trends, allowing you to recognize the products and end users driving Revenue growth and profitability of the market. The report
Global Antibacterial Drugs Market Research Report
This report studies the global Antibacterial Drugs market status and forecast, categorizes the global Antibacterial Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Bayer AG Pfizer Inc. Sanofi GlaxoSmithKline Plc. (GSK) Merck & Co., Inc. AstraZeneca Johnson and Johnson Bristol
Global Antibacterial Drugs Market: Regional Overview
The global antibacterial drugs market features a fairly competitive landscape and leading players include Allergan, Plc., Novartis AG, Bristol Myers Squibb Company, Johnson and Johnson, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi, Pfizer Inc., Bayer AG, notes Transparency Market Research (TMR). Over the years, the competition in the market is expected to intensify. A number of prominent players are focusing on entering into strategic collaborations and mulling